Neuroprotection of retinal ganglion cells by a novel gene therapy construct that achieves sustained enhancement of brain-derived neurotrophic factor/tropomyosin-related kinase receptor-B signaling. (2018)

First Author: Osborne A
Attributed to:  Wellcome Trust MRC Cambridge Stem Cell Institute funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41419-018-1041-8

PubMed Identifier: 30258047

Publication URI: http://europepmc.org/abstract/MED/30258047

Type: Journal Article/Review

Volume: 9

Parent Publication: Cell death & disease

Issue: 10